Preclinical scientific tests suggest that retatrutide may possibly impact obesity-connected most cancers development. In a research led by Marathe et al., retatrutide-induced fat reduction reduced tumor engraftment, delayed tumor onset, and substantially attenuated tumor expansion in pancreatic and lung most cancers models, with higher tumor suppre